Developing BET-ter treatments for cutaneous T-cell lymphoma
Developing BET-ter treatments for cutaneous T-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.26662
Henry K. Wong
|
| 1267-1268 |
HPV: Immunology lessons from an ancient oncotarget
HPV: Immunology lessons from an ancient oncotarget |
|
https://doi.org/10.18632/oncotarget.26606
Sri Krishna,
and Karen S. Anderson
|
| 1269-1270 |
The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma
The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26666
Chaoting Zhang,
Zheming Lu,
and Hongying Huang
|
| 1271-1271 |
Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells
Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells |
|
https://doi.org/10.18632/oncotarget.26654
Audrey Turchick,
Yanfeng Liu,
Weixi Zhao,
Inessa Cohen,
and Peter M. Glazer
|
| 1272-1283 |
A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin |
|
https://doi.org/10.18632/oncotarget.26641
Alice Gerges Geagea,
Manfredi Rizzo,
Abdo Jurjus,
Francesco Cappello,
Angelo Leone,
Giovanni Tomasello,
Céline Gracia,
Sahar Al Kattar,
Liliane Massaad-Massade,
and Assaad Eid
|
| 1284-1305 |
Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas
Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas |
|
https://doi.org/10.18632/oncotarget.26657
Yoichi Ohtaki,
Kimihiro Shimizu,
Reika Kawabata-Iwakawa,
Navchaa Gombodorj,
Bolag Altan,
Susumu Rokudai,
Arito Yamane,
Kyoichi Kaira,
Takehiko Yokobori,
Toshiteru Nagashima,
Kai Obayashi,
Seshiru Nakazawa,
Misaki Iijima,
Takayuki Kosaka,
Toshiki Yajima,
Akira Mogi,
Hiroyuki Kuwano,
Ken Shirabe,
and Masahiko Nishiyama
|
| 1306-1319 |
Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer
Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26663
Ramona Graves-Deal,
Galina Bogatcheva,
Saba Rehman,
Yuanyuan Lu,
James N. Higginbotham,
and Bhuminder Singh
|
| 1320-1333 |
Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia
Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26665
Anudishi Tyagi,
Raja Pramanik,
Sreenivas Vishnubhatla,
Radhika Bakhshi,
and Sameer Bakhshi
|
| 1334-1343 |
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma |
|
https://doi.org/10.18632/oncotarget.26685
Michal Alon,
Rand Arafeh,
Joo Sang Lee,
Sanna Madan,
Shelly Kalaora,
Adi Nagler,
Tereza Abgarian,
Polina Greenberg,
Eytan Ruppin,
and Yardena Samuels
|
| 1344-1344 |
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR |
|
https://doi.org/10.18632/oncotarget.26686
Jordan Madic,
Cécile Jovelet,
Julien Lopez,
Barbara André,
Jean Fatien,
Isabelle Miran,
Aurélie Honoré,
Laura Mezquita,
Benjamin Besse,
Ludovic Lacroix,
and Magali Droniou
|
| 1345-1345 |
